Hypoxia-inducible factor induction by tumour necrosis factor in normoxic cells requires receptor-interacting protein-dependent nuclear factor κB activation

Biochemical Journal

Volumn 370, Issue 3, 2003, Pages 1011-1017

  Jung, YunJin ^a   Isaacs, Jennifer S ^a   Lee, Sunmin ^a   Trepel, Jane ^a   Liu, Zheng Gang ^a   Neckers, Len ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Hypoxia inducible factor 1 ; Nuclear factor ; Receptor interacting protein; Tumour necrosis factor

Indexed keywords

AROMATIC COMPOUNDS; BIOCHEMISTRY; CELLS; PROTEINS;

TUMOUR NECROSIS;

TUMORS;

5,6 DICHLOROBENZIMIDAZOLE RIBOSIDE; COBALT; DACTINOMYCIN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN; RECEPTOR INTERACTING PROTEIN; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; FIBROBLAST; GENE ACTIVATION; GENETIC TRANSCRIPTION; INFLAMMATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN INDUCTION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; RAT; RECEPTOR BINDING; SIGNAL TRANSDUCTION; SURVIVAL; WILD TYPE;

ANIMALS; CELL LINE; EPITHELIAL CELLS; FIBROBLASTS; GENES, REPORTER; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; LIGASES; MICE; NF-KAPPA B; OXYGEN; PROTEIN-SERINE-THREONINE KINASES; PROTEINS; RECEPTOR-INTERACTING PROTEIN SERINE-THREONINE KINASES; TIME FACTORS; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TUMOR NECROSIS FACTOR-ALPHA; TUMOR SUPPRESSOR PROTEINS; UBIQUITIN-PROTEIN LIGASES; VON HIPPEL-LINDAU TUMOR SUPPRESSOR PROTEIN;

ANIMALIA;

EID: 0037444823     PISSN: 02646021     EISSN: None     Source Type: Journal    
DOI: 10.1042/BJ20021279     Document Type: Article

References (61)

1. 2 tension. Proc. Natl. Acad. Sci. U.S.A. 92, 5510-5514
2. Wiener, C. M., Booth, G. and Semenza, G. L. (1996) In vivo expression of mRNAs encoding hypoxia-inducible factor 1. Biochem. Biophys. Res. Commun. 225, 485-488
3. Salceda, S. and Caro, J. (1997) Hypoxia-inducible factor 1α (HIF-1α) protein is rapidly degraded by the ubiquitin-proteasome system under normoxic conditions. Its stabilization by hypoxia depends on redox-induced changes. J. Biol. Chem. 272, 22642-22647
4. 2-dependent degradation domain via the ubiquitin-proteasome pathway. Proc. Natl. Acad. Sci. U.S.A. 95, 7987-7992
5. Maxwell, P. H., Dachs, G. U., Gleadle, J. M., Nicholls, L. G., Harris, A. L., Stratford, I. J., Hankinson, O., Pugh, C. W. and Ratcliffe, P. J. (1997) Hypoxia-inducible factor-1 modulates gene expression in solid tumors and influences both angiogenesis and tumor growth. Proc. Natl. Acad. Sci. U.S.A. 94, 8104-8109
6. Maxwell, P. H., Wiesener, M. S., Chang, G. W., Clifford, S. C., Vaux, E. C., Cockman, M. E., Wykoff, C. C., Pugh, C. W., Maher, E. R. and Ratcliffe, P. J. (1999) The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature (London) 399, 271-275
7. Jiang, B. H., Agani, F., Passaniti, A. and Semenza, G. L. (1997) V-SRC induces expression of hypoxia-inducible factor 1 (HIF-1) and transcription of genes encoding vascular endothelial growth factor and enolase 1: involvement of HIF-1 in tumor progression. Cancer Res. 57, 5328-5335
8. Ravi, R., Mookerjee, B., Bhujwalla, Z. M., Sutter, C. H., Artemov, D, Zeng, Q., Dillehay, L. E., Madan, A., Semenza, G. L. and Bedi, A. (2000) Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1α. Genes Dev. 14, 34-44
9. Salnikow, K., Su, W., Blagosklonny, M. V. and Costa, M. (2000) Carcinogenic metals induce hypoxia-inducible factor-stimulated transcription by reactive oxygen species-independent mechanism. Cancer Res. 60, 3375-3378
10. Wang, G. L. and Semenza, G. L. (1993) Desferrioxamine induces erythropoietin gene expression and hypoxia-inducible factor 1 DNA-binding activity: implications for models of hypoxia signal transduction. Blood 82, 3640-3645
11. Zelzer, E., Levy, Y., Kahana, C., Shilo, B. Z., Rubinstein, M. and Cohen, B. (1998) insulin induces transcription of target genes through the hypoxia-inducible factor HIF-1α/ARNT. EMBO J. 17, 5085-5094
12. Zundel, W., Schindler, C., Haas-Kogan, D., Koong, A., Kaper, F., Chen, E., Gottschalk, A. R., Ryan, H. E., Johnson, R. S., Jefferson, A. B. et al. (2000) Loss of PTEN facilitates HIF-1-mediated gene expression. Genes Dev. 14, 391-396
13. Zhong, H., Chiles, K., Feldser, D., Laughner, E., Hanrahan, C., Georgescu, M. M., Simons, J. W. and Semenza, G. L. (2000) Modulation of hypoxia-inducible factor 1α expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/ AKT/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics. Cancer Res. 60, 1541-1545
14. 2 sensing. J. Biol. Chem. 275, 25130-25138
15. 2 homeostasis. Curr. Opin. Genet. Dev. 8, 588-594
16. Li, J., Post, M., Volk, R., Gao, Y., Li, M., Metais, C., Sato, K., Tsai, J., Aird, W., Rosenberg, R. D. et al. (2000) PR39, a peptide regulator of angiogenesis. Nat. Med. 6, 49-55 [published erratum in Nat. Med. (2000) 6, 356]
17. Li, J., Post, M., Volk, R., Gao, Y., Li, M., Metais, C., Sato, K., Tsai, J., Aird, W., Rosenberg, R. D. et al. (2000) Erratum. Nat. Med. 6, 356
18. Kojima, H., Gu, H., Nomura, S., Caldwell, C. C., Kobata, T., Carmeliet, P., Semenza, G. L. and Sitkovsky, M. V. (2002) Abnormal B lymphocyte development and autoimmunity in hypoxia-inducible factor 1α-deficient chimeric mice. Proc. Natl. Acad. Sci. U.S.A. 99, 2170-2174
19. Lukashev, D., Caldwell, C., Ohta, A., Chen, P. and Sitkovsky, M. (2001) Differential regulation of two alternatively spliced isoforms of hypoxia-inducible factor-1α in activated T lymphocytes. J. Biol. Chem. 276, 48754-48763
20. Carmeliet, P., Dor, Y., Herbert, J. M., Fukumura, D., Brusselmans, K., Dewerchin, M., Neeman, M., Bono, F., Abramovitch, R., Maxwell, P. et al. (1998) Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis. Nature (London) 394, 485-490 [published erratum in Nature (London) (1998) 395, 525]
21. Carmeliet, P., Dor, Y., Herbert, J. M., Fukumura, D., Brusselmans, K., Dewerchin, M., Neeman, M., Bono, F., Abramovitch, R., Maxwell, P. et al. (1998) Erratum. Nature (London) 395, 525
22. Elson, D. A., Ryan, H. E., Snow, J. W., Johnson, R. and Arbeit, J. M. (2000) Coordinate up-regulation of hypoxia inducible factor (HIF)-1α and HIF-1 target genes during multi-stage epidermal carcinogenesis and wound healing. Cancer Res. 60, 6189-6195
23. Maxwell, P. H., Pugh, C. W. and Ratcliffe, P. J. (2001) Activation of the HIF pathway in cancer. Curr. Opin. Genet. Dev. 11, 293-299
24. Semenza, G. L. (2000) Hypoxia, clonal selection, and the role of HIF-1 in tumor progression. Crit. Rev. Biochem. Mol. Biol. 35, 71-103
25. Zhong, H., De Marzo, A. M., Laughner, E., Lim, M., Hilton, D. A., Zagzag, D., Buechler, P., Isaacs, W. B., Semenza, G. L. and Simons, J. W. (1999) Overexpression of hypoxia-inducible factor 1α in common human cancers and their metastases. Cancer Res. 59, 5830-5835
26. Tracey, K. J. and Cerami, A. (1993) Tumor necrosis factor, other cytokines and disease. Annu. Rev. Cell. Biol. 9, 317-343
27. Rothe, J., Gehr, G., Loetscher, H. and Lesslauer, W. (1992) Tumor necrosis factor receptors-structure and function. Immunol. Res. 11, 81-90
28. Hsu, H., Xiong, J. and Goeddel, D. V. (1995) The TNF receptor 1-associated protein TRADD signals cell death and NF-κB activation. Cell (Cambridge, Mass.) 81, 495-504
29. Baud, V. and Karin, M. (2001) Signal transduction by tumor necrosis factor and its relatives. Trends Cell Biol. 11, 372-377
30. Stanger, B. Z., Leder, P., Lee, T. H., Kim, E. and Seed, B. (1995) RIP: a novel protein containing a death domain that interacts with Fas/APO-1 (CD95) in yeast and causes cell death. Cell (Cambridge, Mass.) 81, 513-523
31. Liu, Z. G., Hsu, H., Goeddel, D.V. and Karin, M. (1996) Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-κB activation prevents cell death. Cell (Cambridge, Mass.) 87, 565-576
32. Ting, A. T., Pimentel-Muinos, F. X. and Seed, B. (1996) RIP mediates tumor necrosis factor receptor 1 activation of NF-κB but not Fas/APO-1-initiated apoptosis. EMBO J. 15, 6189-6196
33. Lewis, J., Devin, A., Miller, A., Lin, Y., Rodriguez, Y., Neckers, L. and Liu, Z. G. (2000) Disruption of hsp90 function results in degradation of the death domain kinase, receptor-interacting protein (RIP), and blockage of tumor necrosis factor-induced nuclear factor-κB activation. J. Biol. Chem. 275, 10519-10526
34. Kelliher, M. A., Grimm, S., Ishida, Y., Kuo, F., Stanger, B. Z. and Leder, P. (1998) The death domain kinase RIP mediates the TNF-induced NF-κB signal. Immunity 8, 297-303
35. Baeuerle, P. A. and Baltimore, D. (1988) IκB: a specific inhibitor of the NF-κB transcription factor. Science 242, 540-546
36. Henkel, T., Machleidt, T., Alkalay, I., Kronke, M., Ben-Neriah, Y. and Baeuerle, P. A. (1993) Rapid proteolysis of IκB-α is necessary for activation of transcription factor NF-κB. Nature (London) 365, 182-185
37. Traenckner, E. B., Pahl, H. L., Henkel, T., Schmidt, K. N., Wilk, S. and Baeuerle, P. A. (1995) Phosphorylation of human IκB-α on serines 32 and 36 controls Iκ-B-α proteolysis and NF-κB activation in response to diverse stimuli. EMBO J. 14, 2876-2883
38. Pahl, H. L. (1999) Activators and target genes of Rel/NF-κB transcription factors. Oncogene 18, 6853-6866
39. Farrow, B. and Evers, B. M. (2002) Inflammation and the development of pancreatic cancer. Surg. Oncol. 10, 153-169
40. Garg, A. and Aggarwal, B. B. (2002) Nuclear transcription factor-κB as a target for cancer drug development. Leukemia 16, 1053-1068
41. Hellwig-Burgel, T., Rutkowski, K., Metzan, E., Fandrey, J. and Jelkmann, W. (1999) Interleukin-1β and tumor necrosis factor-α stimulate DNA binding of hypoxia-inducible factor-1. Blood 94, 1561-1567
42. Albina, J. E., Mastrofrancesco, B., Vessella, J. A. Louis, C. A., Henry, Jr, W. L. and Reichner, J. S. (2001) HIF-1 expression in healing wounds: HIF-1α induction in primary inflammatory cells by TNF-α. Am. J. Physiol. Cell Physiol. 281, C1971-C1977
43. Haddad, J. J. and Land, S. C. (2001) A non-hypoxic, ROS-sensitive pathway mediates TNF-α-dependent regulation of HIF-1α. FEBS Lett. 505, 269-274
44. Sandau, K. B., Zhou, J., Kietzmann, T. and Brune, B. (2001) Regulation of the hypoxia-inducible factor 1α by the inflammatory mediators nitric oxide and tumor necrosis factor-α in contrast to desferroxamine and phenylarsine oxide. J. Biol. Chem. 276, 39805-39811
45. Devin, A., Cook, A., Lin, Y., Rodriguez, Y., Kelliher, M. and Liu, Z. (2000) The distinct roles of TRAF2 and RIP in IKK activation by TNF-R1: TRAF2 recruits IKK to TNF-R1 while RIP mediates IKK activation. Immunity 12, 419-429
46. Melillo, G., Taylor, L. S., Brooks, A., Musso, T., Cox, G. W. and Varesio, L. (1997) Functional requirement of the hypoxia-responsive element in the activation of the inducible nitric oxide synthase promoter by the iron chelator desferrioxamine. J. Biol. Chem. 272, 12236-12243
47. Andrews, N. C. and Faller, D. V. (1991) A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. Nucleic Acids Res. 19, 2499
48. Zhong, H., Hanrahan, C., van der Poel, H. and Simons, J. W. (2001) Hypoxia-inducible factor 1α and 1β proteins share common signaling pathways in human prostate cancer cells. Biochem. Biophys. Res. Commun. 284, 352-356
49. Peters, R. T., Liao, S. M. and Maniatis, T. (2000) IKKε is part of a novel PMA-inducible IκB kinase complex. Mol. Cell 5, 513-522
50. Bruick, R. K. and McKnight, S. L. (2001) A conserved family of prolyl-4-hydroxylases that modify HIF. Science 294, 1337-1340
51. 2 sensing. Science 292, 464-468
52. 2-regulated prolyl hydroxylation. Science 292, 468-472
53. Masson, N., Willam, C., Maxwell, P. H., Pugh, C. W. and Ratcliffe, P. J. (2001) Independent function of two destruction domains in hypoxia-inducible factor-α chains activated by prolyl hydroxylation. EMBO J. 20, 5197-5206
54. Iliopoulos, O., Kibel, A., Gray, S. and Kaelin, Jr, W. G. (1995) Tumour suppression by the human von Hippel-Lindau gene product. Nat. Med. 1, 822-826
55. Thornton, R. D., Lane, P., Borghaei, R. C., Pease, E. A., Caro, J. and Mochan, E. (2000) Interleukin 1 induces hypoxia-inducible factor 1 in human gingival and synovial fibroblasts. Biochem. J. 350, 307-312
56. Nelson, G., Paraoan, L., Spiller, D. G., Wilde, G. J. C., Browne, M. A., Djali, P. K., Unitt, J. F., Sullivan, E., Floettmann, E. and White, M R. H. (2002) Multi-parameter analysis of the kinetics of NF-κB signalling and transcription in single living cells. J. Cell Sci. 115, 1137-1148
57. Isaacs, J. S., Jung, Y. J., Mimnaugh, E. G., Martinez, A., Cuttitta, F. and Neckers, L. M. (2002) Hsp90 regulates a VHL-independent HIF-1a degradative pathway. J. Biol. Chem. 277, 29936-29944
58. Maeda, H. and Akaike, T. (1998) Nitric oxide and oxygen radicals in infection, inflammation, and cancer. Biochemistry (Moscow) 63, 854-865
59. Willis, D., Moore, A. R., Frederick, R. and Willoughby, D. A. (1996) Heine oxygenase: a novel target for the modulation of the inflammatory response. Nat. Med. 2, 87-90
60. Means, Jr, R. T. (1995) Erythropoietin in the treatment of anemia in chronic infectious, inflammatory, and malignant diseases. Curr. Opin. Hematol. 2, 210-213
61. Dvorak, H. F., Detmar, M., Claffey, K. P., Nagy, J. A., van de Water, L. and Senger, D. R. (1995) Vascular permeability factor/vascular endothelial growth factor: an important mediator of angiogenesis in malignancy and inflammation. Int. Arch. Allergy Immunol. 107, 233-235